SCHEMBL18556352

SCHEMBL18556352

CC(S)C(=O)NCC(=O)OC(C)(C)C

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.57
LMNA P02545 1/20 0.57
MAPT P10636 1/20 0.57
PTGS2 P35354 1/20 0.57
TDP1 Q9NUW8 1/20 0.57
CYP2D6 P10635 1/20 0.39
PTPRC P08575 2/20 0.38
CTSS P25774 4/20 0.37
CTSK P43235 4/20 0.37
ACE P12821 2/20 0.37
MME P08473 1/20 0.37
CPA1 P15085 1/20 0.37
ACE2 Q9BYF1 1/20 0.37
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA7 P43166 1/20 0.36
CTSL P07711 1/20 0.36
CTSB P07858 1/20 0.36
MMP1 P03956 1/20 0.35
MEN1 O00255 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12017898 0.84 CYP2D6 (0.41) ALDH1A1LMNAMAPTPTGS2TDP1
SCHEMBL29037226 0.82 MEN1 (0.46) ALDH1A1LMNAMAPTPTGS2TDP1
SCHEMBL38660142 0.82 MAPT (0.63) ALDH1A1LMNAMAPTPTGS2TDP1
SCHEMBL20817281 0.82 MAPT (0.63) ALDH1A1LMNAMAPTPTGS2TDP1
SCHEMBL6468610 0.82 MAPT (0.63) ALDH1A1LMNAMAPTPTGS2TDP1
SCHEMBL12884403 0.81 CYP2D6 (0.42) ALDH1A1LMNAMAPTPTGS2TDP1
SCHEMBL27072723 0.81 CYP2D6 (0.39) ALDH1A1LMNAMAPTPTGS2TDP1
SCHEMBL2113714 0.81 CYP2D6 (0.39) ALDH1A1LMNAMAPTPTGS2TDP1
SCHEMBL18924130 0.81 CYP2D6 (0.39) ALDH1A1LMNAMAPTPTGS2TDP1
SCHEMBL18850615 0.78 LMNA (0.59) ALDH1A1LMNAMAPTPTGS2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9988340-B2 Compositions and methods for the treatment of multiple sclerosis CELLIX BIO PRIVATE LIMITED (IN) 2018-06-05 US disclosed
US-9932294-B2 Compositions and methods for the treatment of multiple sclerosis CELLIX BIO PRIVATE LIMITED (IN) 2018-04-03 US disclosed
US-9580383-B2 Compositions and methods for the treatment of multiple sclerosis CELLIX BIO PRIVATE LIMITED (IN) 2017-02-28 US disclosed